1226776-95-9

Basic information

• Product Name: 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile
• Synonyms: 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile;2-(5-AMinopyridin-2-yl)-2-Methylpropanenitrille;2-(5-AMino-2-pyridyl)-2-Methylpropanenitrile;2-(5-Amino-pyridin-2-yl)-2-methyl-propionitrile;5-amino-α,α-dimethyl-2-Pyridineacetonitrile;2-(5-Aminopyridin-2-yl)
• CAS NO: 1226776-95-9
• Molecular Formula: C₉H₁₁N₃
• Molecular Weight: 161.20374
• Product Categories: OLED materials,pharm chemical,electronic
• Mol File: 1226776-95-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 345.922 °C at 760 mmHg
• Flash Point: 163.008 °C
• Appearance: /
• Density: 1.111
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile(1226776-95-9)
• EPA Substance Registry System: 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile(1226776-95-9)

Safety Data

• Hazardous Substances Data: 1226776-95-9(Hazardous Substances Data)

Usage

General Description

2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile is a chemical compound with the molecular formula C10H12N4. It is a derivative of 2-amino-5-picoline and is used in the synthesis of pharmaceuticals and agrochemicals. 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile has potential medicinal properties and is being researched for its applications in drug discovery and development. It is a yellow solid with a molecular weight of 184.23 g/mol and is primarily used in laboratory settings for its chemical reactivity and potential biological activity. Further studies and applications of 2-(5-Aminopyridin-2-yl)-2-methylpropanenitrile may lead to its use in the development of new therapeutic agents and pesticides.

Upstream product

• 1256633-31-4 2-methyl-2-(5-nitropyridin-2-yl)-propanenitrile 

Relevant articles and documents

PROCESS FOR THE PREPARATION OF SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, INTERMEDIATES AND POLYMORPHS THEREOF

The present invention relates to a process for preparation of substituted imidazo[4,5- c]quinoline compounds (the compounds of formula I as described) and intermediates thereof. The present invention also relates to polymorphs of a compound encompassed in the compound of formula I and their use in the treatment of proliferative disorders, particularly cancers.

FUSED HETEROARYLS AND THEIR USES

Provided are certain fused heteroaryls, compositions thereof and methods of use therefor.

SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES

The present invention relates to substituted imidazo[4,5-c]quinoline derivatives of formula (I), wherein R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of the present invention and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammation and angiogenesis related disorders.